EFPIA says anti-counterfeit product verification pilot project has been successful
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has published the results of its product verification system pilot project to prevent counterfeiting of medicines. The pilot, held in Sweden between September 2009 and January 2010, successfully demonstrated that a product verification system at the point of dispense, based on a two-dimensional data matrix, is both robust and effective.
When the project was unveiled last fall, Brian Ager, director general of the association, said: 'This EFPIA initiative represents an important contribution to meeting the challenge posed by counterfeit medicines entering the legitimate supply chain (The Pharma Letter October 21, 2009).
Response to EC proposal for mass serialization
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze